BluMaiden utilizes artificial intelligence (AI) to revolutionize small-molecule drug discovery by streamlining the process of designing new drugs. By harnessing AI algorithms, BluMaiden efficiently analyzes massive amounts of data to predict how molecules will interact with biological targets, enabling the identification of potential drug candidates more quickly and accurately. This innovative approach has the potential to significantly accelerate the development of new medications and improve treatment options for various diseases.
Source link
Hong Kong actor Nicholas Tse sells premium sausages online, earns US$207 million in 4 years
Hong Kong singer and actor Nicholas Tse has achieved great success in the food industry, selling 1.5 billion yuan-worth (US$207 million) of sausages in China over three years through his company Chef Nic Π. The brand has been recognized as the nationwide sales champion for three consecutive years by Euromonitor International. Tse, who has a large fan base in mainland China and Hong Kong, has also garnered accolades for his cooking skills in a variety...
Read more